{"id":"NCT00929695","sponsor":"Fred Hutchinson Cancer Center","briefTitle":"Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease","officialTitle":"A Phase III Study to Determine Efficacy and Safety of Low-Dose Glucocorticoids for Initial Treatment of Acute Graft-versus-Host Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-06","primaryCompletion":"2013-07","completion":"2015-12-14","firstPosted":"2009-06-29","resultsPosted":"2014-10-09","lastUpdate":"2017-08-21"},"enrollment":164,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Graft Versus Host Disease","Recurrent Adult Acute Lymphoblastic Leukemia"],"interventions":[{"type":"DRUG","name":"prednisone","otherNames":["DeCortin","Deltra"]},{"type":"DRUG","name":"methylprednisolone","otherNames":["Depo-Medrol","Medrol","MePRDL","Solu-Medrol","Wyacort"]},{"type":"OTHER","name":"questionnaire administration","otherNames":[]}],"arms":[{"label":"Arm I (Low-dose)","type":"EXPERIMENTAL"},{"label":"Arm II (Standard-dose)","type":"ACTIVE_COMPARATOR"}],"summary":"This randomized phase III trial is studying low-dose prednisone or methylprednisolone to see how well they work compared with standard-dose prednisone or methylprednisolone in treating patients with newly diagnosed acute graft-versus-host disease (GVHD). Glucocorticoids, such as prednisone or methylprednisolone at a starting dose of 2 mg/kg/day are standard treatment for acute graft-versus-host disease caused by a donor stem cell transplant. It is not yet known whether low-dose glucocorticoids are more effective than standard-dose glucocorticoids in treating acute graft-versus-host-disease","primaryOutcome":{"measure":"Mean Cumulative Prednisone Dose (mg/kg) Over 42 Days From the Start of Treatment","timeFrame":"At day 42 after initiation of treatment","effectByArm":[{"arm":"Grade IIa GVHD; 0.5 mg/kg/d Prednisone","deltaMin":22.2,"sd":13.7},{"arm":"Grade IIa GVHD; 1.0 mg/kg/d Prednisone","deltaMin":27.1,"sd":12.7},{"arm":"Grade IIb-IV GVHD; 1.0 mg/kg/d Prednisone","deltaMin":38.4,"sd":14.1},{"arm":"Grade IIb-IV GVHD; 2.0 mg/kg/d Prednisone","deltaMin":41.3,"sd":12.1}],"pValues":[{"comp":"OG000 vs OG001","p":"0.08"},{"comp":"OG002 vs OG003","p":"0.4"}]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":81},"commonTop":[]}}